Combinatory lung tumor inhibition by myo-inositol and iloprost/rapamycin: association with immunomodulation.
Sign Up to like & getrecommendations! Published in 2022 at "Carcinogenesis"
DOI: 10.1093/carcin/bgac019
Abstract: Although both preclinical and clinical studies have suggested that myo-inositol (MI) may be a safe and effective lung cancer chemopreventive agent, its efficacy is moderate. To test whether the chemopreventive agents iloprost (IL) or rapamycin… read more here.
Keywords: lung; rapamycin; iloprost rapamycin; lung tumors ... See more keywords